Transgene SA (0OCQ.L)

One Biosciences announces the appointment of Hedi Ben Brahim as Chief Executive Officer

PARIS, Sept. 07, 2023 (GLOBE NEWSWIRE) -- One Biosciences, a biotech leveraging the power of single-cell analysis and AI to unlock a new wave of targets and precision medicines for a broad range of difficult-to-treat diseases, today announced the appointment of Mr. Hedi Ben Brahim as its Chief Executive Officer (CEO). Hedi is a recognized leader in the biotechnology industry, joining from Transgene (Euronext: TNG) where he served as Chief Executive Officer. Mr. Ben Brahim was appointed CEO as pa